Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Arc-1 vs Queen RX

Arc-1
Graded #417

Lower grade

vs+9.700000000000003
Queen RX
Graded #214

Higher grade

The verdict

Queen RX takes it — 66/100 to 56.3/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +32
44
76
Dose & formulationQueen RX +3
54
57
Clinical oversightArc-1 +3
72
69
Labs & monitoringQueen RX +1
52
53
FulfillmentQueen RX +13
62
75
Contract termsEven
61
61
Arc-1 · left barQueen RX · right bar

The numbers

MetricArc-1Queen RX
WeighScore56.3/10066/100
GradeCC
Scorecard rank#417#214
Semaglutide$200/mo (0.5 mg dose, compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$200/mo (2.5 mg dose, compounded)Not disclosed
CoverageCoverage not published45 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Arc-1

Graded #417 · C

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Per-dose purchasing — no subscription or membership required
  • 25% off plus free shipping promotion
  • Broader longevity formulary (rapamycin, NAD+, sermorelin)
  • LegitScript Certified badge now displayed on product pages

Where it loses points

  • No legal entity name or address disclosed
  • State availability not disclosed
  • No named clinicians or pharmacy partners
  • Per-dose pricing still climbs with dose (semaglutide 2.5mg is $549.99/mo, tirzepatide 7.5mg $399.99/mo)
Queen RX

Graded #214 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard